Skip to main content

Cedars Worldwide Operations & Customer Services

Clinical Faculty Opportunities

Cedars‑Sinai is known internationally for providing high-quality, patient-centered care and developing innovative approaches to healthcare delivery and treatment. Our physicians deliver everything from primary care to specialized treatments for rare, complex and advanced illnesses. They work with the most innovative technology in the industry and lead the way in medical advancements. From utilizing stem cells to regrow heart tissue and cure disease to the nonsurgical replacement of damaged heart surgery, our clinicians are continuously on the forefront of medical breakthroughs, saving lives every day.

For more information contact Academic & Leadership Search at

Department of Anesthesiology

Department of Medicine

  • Bone Marrow Transplant
  • Division Director - Hematology-Oncology
  • Division Director, Rheumatology
  • Inflammatory Bowel and Immunobiology Research Institute
  • Medical Director, Lung Transplant

Department of Neurology

Department of Neurosurgery Whittier:

  • Neurosurgeon
  • Neuro-Oncology

Department of OB-GYN

  • Gynecologic Oncology

Department of Orthopaedics

Department of Pediatrics

  • Pediatric Undiagnosed Diseases
  • Pediatric Hem-Onc

Department of Psychiatry

Department of Radiation Oncology

  • Breast Radiation Oncologist

Department of Surgery

  • Surgical Director - Lung Transplant

Cedars-Sinai Chosen for Breast Cancer Study

Monica Mita, MD, associate professor of Medicine and co-director of the Experimental Therapeutics Program at the Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute, is the principal investigator for the portion of the clinical trial to be conducted at Cedars-Sinai. The two other sites for the multicenter study are Baylor Sammons Cancer Center – US Oncology Network, Dallas, and US Oncology Network, Tyler, Texas.

Obesity May be Linked to Microorganisms Living in the Gut

“This is the first large-scale human study to show an association between gas production and body weight, and this could prove to be another important factor in understanding one of the many causes of obesity,” said lead author Ruchi Mathur, MD, director of the Diabetes Outpatient Treatment and Education Center in the Cedars-Sinai Division of Endocrinology.

Blood Test Could Help Gastrointestinal Patients

For the first time, a simple blood test may be the best way to determine if a patient is suffering from irritable bowel syndrome, or another serious condition such as inflammatory bowel disease, according to Cedars-Sinai physician researcher Mark Pimentel, MD, lead author of a multicenter clinical trial.

For more information contact Academic and Leadership Search at